Live News EQUITY FLASH L impact Nov 03, 2026, 01:40 PM UTC Wedbush Raises Beam Therapeutics Price Target to $30 From $28 Wedbush kept its Outperform rating on Beam Therapeutics. BEAM SquawkNews Desk